The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications
about
HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settingsProliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.Renal transplantation in patients with HIV.Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 miceHIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytesCurrent and Novel Inhibitors of HIV ProteaseMetabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.GRP78 plays an essential role in adipogenesis and postnatal growth in mice.Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunctionFiber type-specific differences in glucose uptake by single fibers from skeletal muscles of 9- and 25-month-old rats.Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy.Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.Fenofibrate in the treatment of dyslipidemia associated with HIV infection.Management of fat accumulation in patients with HIV infection.Antiretroviral therapy: effects on orofacial health and health care.Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced DyslipidaemiaCoronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.Placental leptin mRNA expression and serum leptin levels in pre-eclampsia associated with HIV infection.Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q28088839-881DDD7B-F519-4B37-9605-E7AB668AEAB7Q33880079-9B8CBCF1-C60D-4CC8-A9E4-3481BE8B3DD6Q34079397-0C7842AE-C954-47E4-9152-A1A6CA5A738EQ34299021-A2F89CDE-8743-4548-875D-1E4800ECF42FQ34333367-7FA60A30-D78D-4438-9AF9-F61D9DADDAEBQ34349192-A4590808-7D99-4010-8444-2294F4D03B80Q34637857-7E330BAB-A235-43A5-9477-57BB8180E281Q35259915-E8FCFC1E-9EE8-4C1A-BD78-52E4E1FF6A1DQ36250357-34A2CECF-35E0-4073-A1D6-5EA46C6702AAQ36402487-A9F718E4-193D-4D0C-91BF-A5928F52A928Q36615162-E0270872-6E14-4525-AF5B-A2B095F54DD6Q36835027-74C676C1-D1B9-4B93-8B25-34733A5E2E61Q36895097-679358A2-3F9D-4560-9150-86977F4EB03FQ37111533-CB6354A6-9233-4D57-9BB0-5E015C2F078DQ37250997-B772A443-8C48-4281-A283-C0C840CFAB59Q37770249-593AD4DB-01D0-4769-AF44-BFC0B320DB7AQ37899071-0D1C601F-4AEB-477D-ADDC-5F9669E3D869Q38093238-EE13E7D8-2951-499A-AC7B-0571D9C7451BQ38598879-48914685-2EC4-4A9B-95BC-F2753E8DE609Q39165028-10BCC0AC-9C54-436D-95D5-DADA97FBE531Q39515202-6BE951D8-EFAB-4733-8D80-47F4568ADD23Q40520851-5EFF5548-879B-4A5C-BD66-DAD9F492BDEDQ42700015-9EFE791E-9DD4-4C6B-830C-2BEFA5D17149Q43865605-C4FBAFD6-F8AF-4321-996F-B09D52703D1EQ58549748-4F40EC51-68FC-4D6B-B612-311923C2AFD1
P2860
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The role of protease inhibitor ...... isms and clinical implications
@ast
The role of protease inhibitor ...... isms and clinical implications
@en
The role of protease inhibitor ...... isms and clinical implications
@nl
type
label
The role of protease inhibitor ...... isms and clinical implications
@ast
The role of protease inhibitor ...... isms and clinical implications
@en
The role of protease inhibitor ...... isms and clinical implications
@nl
prefLabel
The role of protease inhibitor ...... isms and clinical implications
@ast
The role of protease inhibitor ...... isms and clinical implications
@en
The role of protease inhibitor ...... isms and clinical implications
@nl
P2093
P2860
P356
P1476
The role of protease inhibitor ...... isms and clinical implications
@en
P2093
Aouatef Bellamine
Donald P Kotler
Mustafa A Noor
Oliver P Flint
Phil B Hylemon
Rex A Parker
P2860
P356
10.1177/0192623308327119
P407
P577
2009-01-26T00:00:00Z